Four Biomedical Engineering teams made it to the finals of The University of Texas Idea to Product (I2P) competition placing 2nd, 3rd, 4th, and 5th in the finals on Saturday.
Four Biomedical Engineering teams made it to the finals of The University of Texas Idea to Product (I2P) competition placing 2nd, 3rd, 4th, and 5th in the finals on Saturday. A team of Mechanical Engineering students won 1st place.
The I2P competition is a campus-wide competition and is a major program of the UT Technology Entrepreneurship Society (TES). The purpose of the I2P competition is to encourage the next generation of entrepreneurs and help students design technology-based products and look at potential markets. A total of 40 teams entered the competition and 14 were chosen to advance to the semifinals on Friday. Six teams then advanced to the finals on Saturday. The BME winners and their prizes are:
--------------------------------------------------------------------------------
2nd Place: Ted Gaubert $2,000
(supervising professor: Wolfgang Frey)
Destruction of Cancerous Cells Using Magnetic NanoParticles
This product is a novel cancer therapy based on magnetic nanoparticles that locally destroy cancer cells.
3rd Place: Sudhir Kasturi, Archit Sanghvi, and Ranjit Nayak (MBA student) $1,000
(supervising professors: Krish Roy and Christine Schmidt)
ImmunoTrain Technologies
This product features single injectable, multi-factor combinatorial, biomaterial formulations containing potent and critical molecules to train one's own immune system to eradicate tumors and fight infectious diseases.
4th Place: Hyohoon Choi $500
(supervising professor: Al Bovik)
Automated Multiplex-Fluorescence In-Situ Hybridization (M-FISH)
M-Fish technology provides a means to visualize and analyze chromosomes in order to study cancers, genes, and various genetic diseases.
5th Place: Jignesh Shah $200
(supervising professor: Stas Emelianov)
Imaging System to Detect Rheumatoid Arthritis (IDA)
The IDA instrument is used to quickly and non-invasively detect rheumatoid arthritis in patients at an early stage thus allowing for effective treatment.
--------------------------------------------------------------------------------
All four of the BME teams made excellent presentations - a clear reflection of the enormous amount of time and energy put into their preparation.
